secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001213900-25-025805
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations reports ~$22M preliminary 2024 revenue, almost 4x YoY; Q1 2025 est $6.4M
--------------------------------------------------------------------------------

- Preliminary 2024 revenue ~$22M (unaudited), up from ~$5.5M in 2023; gross margin improved to 36.9% from 12.3%.
- Q1 2025 estimated revenue ~$6.4M with ~45% gross margin; installations rose from 64 to 78 systems.
- SSi Mantra systems installed at 75 hospitals; performed 3,500+ surgeries with zero device-related mortality.
- Expects FDA & CE approvals by end of 2025/early 2026; also received CDSCO approval for telesurgery in India.
- Appointed independent directors Tim Adams and Dr. Frederic Moll (founder of Intuitive Surgical) to board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025025805/0001213900-25-025805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390025025805/ea0236284-8k_ssinno.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-025805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer